Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-angiogenic Therapy”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)UnknownNCT04446091
What this trial is testing

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Who this might be right for
Colorectal Cancer
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355361
What this trial is testing

Huaier Granule and Proteinuria

Who this might be right for
ProteinuriaBreast Cancer Patients
Fudan University 120
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Early research (Phase 1)Study completedNCT01661400
What this trial is testing

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors

Who this might be right for
GliomaNeuroectodermal Tumors, PrimitiveWilms Tumor+4 more
Washington University School of Medicine 14
Not applicableUnknownNCT03567135
What this trial is testing

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Who this might be right for
Glioblastoma
Fuzhou General Hospital 60
Early research (Phase 1)Study completedNCT00454649
What this trial is testing

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Who this might be right for
Neoplasms
Pfizer 102
Very early researchStudy completedNCT00727948
What this trial is testing

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Who this might be right for
Breast CancerAngiogenesis
University of Vermont 11
Not applicableNot Yet RecruitingNCT06423144
What this trial is testing

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01354431
What this trial is testing

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06537505
What this trial is testing

Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

Who this might be right for
Solid Tumor
Beidahuang Industry Group General Hospital 60
Not applicableNot Yet RecruitingNCT06858956
What this trial is testing

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083375
What this trial is testing

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

Who this might be right for
Extensive Small Cell Lung Cancer
Zhijie Wang 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314372
What this trial is testing

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 86
Not applicableUnknownNCT05285579
What this trial is testing

Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer

Who this might be right for
Renal Cell CarcinomaRenal CancerRenal Cancer Metastatic
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06884345
What this trial is testing

METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Early research (Phase 1)Study completedNCT00874588
What this trial is testing

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Fukushima Medical University 6
Not applicableNot Yet RecruitingNCT07206511
What this trial is testing

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

Who this might be right for
Unresectable Hepatocellular Carcinom
Shanghai Zhongshan Hospital 278
Testing effectiveness (Phase 2)Study completedNCT00076011
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Pfizer 52
Load More Results